Want to create an interactive transcript for this episode?
Podcast: One Thing Today in Tech
Episode: Biocon buys Viatris biosimilars unit for $3.34 bln; Infosys launches ‘Metaverse Foundry’; Prime closes Fund IV at $120 mln
Description: Biocon Biologics has struck a $3.335 billion cash-and-stock deal with US pharmaceuticals company Viatris to acquire its global biosimilars business including rights in the partnered in-licensed portfolio. Infosys has launched a ‘metaverse foundry’ to fast-track its customers’ adoption of the online environment. And Prime Venture Partners, a Bangalore VC firm focused on early-stage startups has closed its latest fund at $120 million.
Notes:
Biocon Biologics acquires Viatris’s biosimilars unit for $3.35 billion
Biocon Biologics has struck a deal with US pharmaceuticals company Viatris to acquire its global biosimilars business including rights in a partnered in-licensed portfoli...